Literature DB >> 24141471

Sudden hearing loss associated with methylphenidate therapy.

Ugur Karapinar1, Omer Saglam, Engin Dursun, Bilal Cetin, Nergis Salman, Murat Sahan.   

Abstract

An 8-year-old child diagnosed with attention deficit/hyperactivity disorder presented to our Department of Otolaryngology 4 days after suffering hearing loss, loss of balance, tinnitus, and fullness sensation of the left ear. Her symptoms occured with the first dose of methylphenidate. The medical history and physical examination revealed no other diseases associated with sudden hearing loss. The audiogram revealed a total hearing loss on the left ear. Stapedial reflexes, distortion product and transient-evoked otoacoustic emissions were absent in left ear. The absence of clinical, laboratory and radiological evidence of a possible cause for complaints, an association between methylphenidate and sudden hearing loss was suggested. The patient received a standard course of oral corticosteroid and hyperbaric oxygen therapy. Weekly otological and audiological examinations were performed. Conservative and medical treatments offered no relief from hearing loss. Sudden hearing loss is a serious and irreversible adverse effect of methylphenidate. Therefore, the risk of hearing loss should be taken into consideration when initiating methylphenidate therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24141471     DOI: 10.1007/s00405-013-2763-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  10 in total

Review 1.  Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

Authors:  David S Haynes; Matthew O'Malley; Seth Cohen; Kenneth Watford; Robert F Labadie
Journal:  Laryngoscope       Date:  2007-01       Impact factor: 3.325

Review 2.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

Review 3.  The role of methylphenidate in psychiatry.

Authors:  R G Klein
Journal:  Arch Gen Psychiatry       Date:  1995-06

Review 4.  National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-02       Impact factor: 8.829

5.  Iloprost-induced sudden hearing loss.

Authors:  E Dursun; S Dogru; H Cincik; E Cekin; A Gungor; E Poyrazoglu
Journal:  J Laryngol Otol       Date:  2007-03-15       Impact factor: 1.469

Review 6.  Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.

Authors:  H Murphy-Lavoie; S Piper; R E Moon; T Legros
Journal:  Undersea Hyperb Med       Date:  2012 May-Jun       Impact factor: 0.698

Review 7.  Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients.

Authors:  Mani H Zadeh; Ian S Storper; Jaclyn B Spitzer
Journal:  Otolaryngol Head Neck Surg       Date:  2003-01       Impact factor: 3.497

8.  Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis.

Authors:  Chu-Yao Chen; Chris Halpin; Steven D Rauch
Journal:  Otol Neurotol       Date:  2003-09       Impact factor: 2.311

9.  Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD.

Authors:  James Lee; Natalie Grizenko; Venkataramana Bhat; Sarojini Sengupta; Anna Polotskaia; Ridha Joober
Journal:  BMC Psychiatry       Date:  2011-04-21       Impact factor: 3.630

10.  Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy.

Authors:  Emanuele Ferri; Antonio Frisina; Anna Chiara Fasson; Enrico Armato; Giacomo Spinato; Maurizio Amadori
Journal:  ISRN Otolaryngol       Date:  2012-02-19
  10 in total
  3 in total

1.  Adverse reactions of Methylphenidate in children with attention deficit-hyperactivity disorder: Report from a referral center.

Authors:  Zahra Khajehpiri; Javad Mahmoudi-Gharaei; Toktam Faghihi; Iman Karimzadeh; Hossein Khalili; Mostafa Mohammadi
Journal:  J Res Pharm Pract       Date:  2014-10

2.  The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder.

Authors:  Onur İsmi; Veli Yildirim; Yusuf Vayisoglu; Anis Togrul; Fevziye Toros; Murat Unal
Journal:  Int Arch Otorhinolaryngol       Date:  2017-08-07

Review 3.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.